The long term goal of this project is to detect, diagnose, and monitor progression of Alzheimer's disease (AD). This project has studied 176 AD subjects and developed multislice 1H MRSI (TE=30) which measures N-acetyl aspartate (MAA), myo-inositol, and other metabolites in surface cortex and hippocampus. This will be used with segmented/volumed MRI, genetic and neuropsychological tests. Subjects (from the UCSF and the Northern California Alzheimer s Center) will include: AD (N=220), Frontotemporal Dementia (n=50), non-demented subjects with a Clinical Dementia Rating of 0.5 (n-100), and age matched Controls (n=140). Subjects will be followed to autopsy. Hypotheses: 1) Regional metabolic changes: The greatest antemortem changes of MRS-detectable metabolites (especially NAA and myo-inositol) occur in the hippocampus and in temporoparietal cortex in AD. 2) Anatomical- neuropsychological correlations: Neuron loss and other metabolite change (detected by MRSI) in specific brain regions is associated with specific types of cognitive impairment. 3) Diagnosis of AD: 1H MRSI and MRI, together with clinical measures provide more sensitive and specific diagnosis of AD than do MRI and clinical measures alone. 4) Diagnosis of Frontotemporal dementia (FTD): FTD is associated with both decreased NAA in the frontal lobes and genetic mutation in 17q21-22, and can be reliably distinguished from AD. Finally, a pilot study will be performed to determine the extent that 1H MRSI and MRI together with genetic and clinical measures identify changes consistent with early AD in non demented subjects (n=100) with a Clinical Dementia Rating of 0.5, compared to genetic and clinical measures alone. It is expected that this project will lead to the development of improved antemortem diagnostic technique (which could be used by many MR scanners) for: assessment of, screening of subjects at risk for, and monitoring progression of dementia.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG010897-15
Application #
6137039
Study Section
Diagnostic Radiology Study Section (RNM)
Program Officer
Buckholtz, Neil
Project Start
1992-07-01
Project End
2001-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
15
Fiscal Year
2000
Total Cost
$507,372
Indirect Cost
Name
Northern California Institute Research & Education
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94121
Mohlenhoff, Brian S; O'Donovan, Aoife; Weiner, Michael W et al. (2017) Dementia Risk in Posttraumatic Stress Disorder: the Relevance of Sleep-Related Abnormalities in Brain Structure, Amyloid, and Inflammation. Curr Psychiatry Rep 19:89
Parthasarathy, Vishnu; Frazier, Darvis T; Bettcher, Brianne M et al. (2017) Triglycerides are negatively correlated with cognitive function in nondemented aging adults. Neuropsychology 31:682-688
Taylor, Alexander N W; Kambeitz-Ilankovic, Lana; Gesierich, Benno et al. (2017) Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer's disease. Alzheimers Dement 13:225-235
Mueller, Susanne G; Weiner, Michael W (2017) Amyloid Associated Intermittent Network Disruptions in Cognitively Intact Older Subjects: Structural Connectivity Matters. Front Aging Neurosci 9:418
Durazzo, Timothy C; Korecka, Magdalena; Trojanowski, John Q et al. (2016) Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers. J Alzheimers Dis 54:99-107
Scherling, Carole S; Wilkins, Sarah E; Zakrezewski, Jessica et al. (2016) Decreased Self-Appraisal Accuracy on Cognitive Tests of Executive Functioning Is a Predictor of Decline in Mild Cognitive Impairment. Front Aging Neurosci 8:120
Durazzo, Timothy C; Mattsson, Niklas; Weiner, Michael W et al. (2016) Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders. Nicotine Tob Res 18:204-11
Araque Caballero, Miguel Ángel; Brendel, Matthias; Delker, Andreas et al. (2015) Mapping 3-year changes in gray matter and metabolism in A?-positive nondemented subjects. Neurobiol Aging 36:2913-2924
Song, Zhuang; Insel, Philip S; Buckley, Shannon et al. (2015) Brain amyloid-? burden is associated with disruption of intrinsic functional connectivity within the medial temporal lobe in cognitively normal elderly. J Neurosci 35:3240-7
Durazzo, Timothy C; Mattsson, Niklas; Weiner, Michael W et al. (2014) History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress. Drug Alcohol Depend 142:262-8

Showing the most recent 10 out of 157 publications